All lobbying filings

Carol G Holladay & Associates

Carol G Holladay & Associates filed a Q4 report for Pharmadva on January 20, 2026, reporting $8,000 in lobbying income.

Lobbying for Pharmadva · manufacturing & distribution medical device contracted through prosthetics in VA Med Ctrs

As filed: CAROL G HOLLADAY & ASSOCIATES for PHARMADVA.

All filings by Carol G Holladay & Associates · Everything Pharmadva has reported

Filing · LD-2 quarterly report Q4 report

Reporting period

4th Quarter 2025

Oct 1 - Dec 31 · Posted Jan 20, 2026

Income

$8,000

What the client paid this registrant for the period.

Client based in

New York

Official filing document

Government bodies contacted 3

The chambers, agencies and offices the filer named. It does not say who inside them was contacted, or when. Each name opens every filing that named the same body.

Lobbying activity 1

Veterans

Congressional Meetings to introduce PharmAdva's Medacube to Members of Congress and their staffs. Buy American issues and tariff increases in China. Medacube has 2 small components made in China and is trying to move manufacturing those components to US. HR 2148 - Veteran Caregiver Reeducation, Reemployment, and Retirement Act, meeting to support with Cong. Bergman (MI). S. 1874 -Title VIII Nursing Workforce Reauthorization Act of 2025 reauthorizes through FY2026 and revises various programs and activities of the Centers for Medicare & Medicaid Services - communicated support with NY, WY, FL, and TN Delegations. VA Meetings with VISNs 3 and 5 Home-Based Primary Care Departments, Meetings with NY Delegation to support research base in Rochester and relocating manufacturing of some components to US.

Bills named in this filing 2

H.R. 2148
Veteran Caregiver Reeducation, Reemployment, and Retirement Act
S. 1874
Title VIII Nursing Workforce Reauthorization Act of 2026

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.